<  Back to the Polytechnique Montréal portal

Decentralized clinical trials are better for the participants and for the planet: the case study of a double-blind randomized controlled trial in Singapore (PROMOTE study)

Lisa R. Fries, N. Khaled, Ivan Viveros Santos, Elvira Suniega-Tolentino, Motshewa Sesing, Melissa P. S. Toh, Chui Yuen Yang, Shiao-Yng Chan and Sara Colombo Mottaz

Article (2025)

Open Acess document in PolyPublie and at official publisher
[img]
Preview
Open Access to the full text of this document
Published Version
Terms of Use: Creative Commons Attribution
Download (1MB)
Show abstract
Hide abstract

Abstract

Introduction: Novel technologies have enabled the decentralization of many aspects of clinical trials, but little research has been done on the impact of these changes on the participant experience, trial operations, or the environment.

Methods: A fully decentralized clinical trial conducted in Singapore is used as a case study to evaluate the operational outcomes, environmental impact (via life cycle assessment), and participants experience (qualitative interviews) of the decentralized model compared to a traditional study with in-person visits.

Results: The decentralized study achieved high participant retention rates (97%) and high completion rates for clinical data, even for biological samples. Participants found the decentralized model to be convenient and safe, especially during the pandemic. Moreover, the decentralized model was found to be more environmentally friendly and less detrimental to human health compared to traditional face-to-face clinical trials, primarily by reducing participants’ use of cars for site visits.

Discussion: While this study focused on the environmental impact, it is important to consider other factors such as participant safety, convenience, and data quality when evaluating the suitability of a decentralized clinical trial approach. Careful planning of data flow, database structure, and data protection measures is essential. This study contributes to improving the environmental footprint of clinical trials. Environmental sustainability should be among the factors that are evaluated when selecting trial models. Decentralized and hybrid clinical trials offer efficiency, effectiveness, and environmental benefits. Further research and adoption of these approaches are encouraged.

Uncontrolled Keywords

Additional Information: Le matériel supplémentaire n'est pas disponible présentement.
Department: Department of Chemical Engineering
Research Center: CIRAIG - International Reference Centre for the Life Cycle of Products, Processes and Services
Funders: Singapore Institute of Clinical Sciences, Agency for Science, Technology and Research, Nestlé (Singapore), Nestlé (Switzerland)
PolyPublie URL: https://publications.polymtl.ca/61974/
Journal Title: Frontiers in Public Health (vol. 12)
Publisher: Frontiers Media SA
DOI: 10.3389/fpubh.2024.1508166
Official URL: https://doi.org/10.3389/fpubh.2024.1508166
Date Deposited: 16 Jan 2025 15:18
Last Modified: 13 Jan 2026 20:06
Cite in APA 7: Fries, L. R., Khaled, N., Viveros Santos, I., Suniega-Tolentino, E., Sesing, M., Toh, M. P. S., Yang, C. Y., Chan, S.-Y., & Mottaz, S. C. (2025). Decentralized clinical trials are better for the participants and for the planet: the case study of a double-blind randomized controlled trial in Singapore (PROMOTE study). Frontiers in Public Health, 12, 14 pages. https://doi.org/10.3389/fpubh.2024.1508166

Statistics

Total downloads

Downloads per month in the last year

Origin of downloads

Dimensions

Repository Staff Only

View Item View Item